by jhscmo | May 28, 2022 | Press Releases
Jubilant HollisterStier LLC Enters into Cooperative Agreement of $149.6Mn with US Government to Expand Critical Vaccine Manufacturing Capacity 05.28.2022, Nabia, India: Jubilant Pharmova Limited has announced today that Jubilant Pharma Limited, a wholly owned...
by jhscmo | Mar 16, 2022 | Press Releases
Jubilant HollisterStier Receives Five CMO Leadership Awards 2022 03.16.2022, Spokane, WA & Montreal, CA: Jubilant HollisterStier LLC, a leading pharmaceutical contract manufacturer and a subsidiary of Jubilant Pharma Limited, today announced that it has received...
by jhscmo | Nov 11, 2021 | Press Releases
Jubilant HollisterStier to Host Groundbreaking Ceremony for $92 Million Expansion 11.11.2021, Noida, India: Jubilant HollisterStier LLC, a pharmaceutical contract manufacturer that is part of Jubilant Pharma Limited, announced plans to host a groundbreaking ceremony...
by jhscmo | Jul 14, 2021 | Media Mentions
Jubilant HollisterStier to Pump $76M into Montreal Facility On July 14 2021, Fierce Pharma reported on the $76Mn expansion of the Jubilant HollisterStier CDMO facility in Montreal, Canada. This investment doubled the facility’s drug production capacity and added new,...
by jhscmo | Jun 15, 2021 | Press Releases
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN® 06.15.2021, Malvern, PA: Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure...
